Clinical trial
Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With…
NCT00272805 · Cardiovascular Clinical Sciences Inc, Industry · Completed
Key facts
| NCT number | NCT00272805 |
|---|---|
| Title | Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg |
| Official title | Prospective, Randomized, Controlled Assessment of Once-Daily Controlled Release COREG CR vs Twice-Daily COREG Immediate Release(IR)on Measures of Compliance and Quality of Life in Patients With Heart Failure and Left Ventricular Systolic Dysfunction |
| Lead sponsor | Cardiovascular Clinical Sciences Inc, Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Heart Failure |
| Intervention type | Drug |
| Interventions | carvedilol |
| Enrollment | 400 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Feb 18, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: